[1]
Bandelier, C. 2009. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies. Swiss Medical Weekly. 139, 0304 (Jan. 2009), 41–46. DOI:https://doi.org/10.4414/smw.2009.12441.